ArticleBMJ open2024

A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.

Hilary Glen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.